Stryker Corporation SYK
i
Market dataready · fetched 2026-11-13T02:24:46.332Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T00:13:31.529574169Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-13T02:24:45.744070+00:00
Stryker Corporation options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 325.96 | 31.5% | 5.0% | 300.80 | 30.8% | 4.2% |
| 25Δ | 323.44 | 32.0% | 4.3% | 302.84 | 31.0% | 3.7% |
| 30Δ | 320.91 | 32.4% | 3.7% | 304.89 | 31.1% | 3.3% |
| 35Δ | 318.75 | 32.6% | 3.3% | 306.94 | 31.3% | 2.8% |
| 40Δ | 316.78 | 32.7% | 2.9% | 308.99 | 31.4% | 2.4% |
| 45Δ | 314.82 | 32.8% | 2.5% | 310.99 | 31.6% | 2.1% |
| 50Δ | 312.86 | 32.9% | 2.2% | 312.95 | 31.9% | 1.8% |
| 55Δ | 310.90 | 33.0% | 1.8% | 314.91 | 32.2% | 1.5% |
| 60Δ | 308.76 | 33.2% | 1.5% | 316.86 | 32.4% | 1.3% |
| 65Δ | 306.47 | 33.7% | 1.3% | 318.82 | 32.7% | 1.0% |
| 70Δ | 304.19 | 34.1% | 1.1% | 321.02 | 32.7% | 0.8% |
| 75Δ | 301.91 | 34.5% | 0.9% | 323.58 | 32.4% | 0.6% |
| 80Δ | 299.41 | 34.8% | 0.7% | 326.15 | 32.0% | 0.5% |
20Δ
- Pseudo strike
- 325.96
- IV
- 31.5%
- B/E move
- 5.0%
- Pseudo strike
- 300.80
- IV
- 30.8%
- B/E move
- 4.2%
25Δ
- Pseudo strike
- 323.44
- IV
- 32.0%
- B/E move
- 4.3%
- Pseudo strike
- 302.84
- IV
- 31.0%
- B/E move
- 3.7%
30Δ
- Pseudo strike
- 320.91
- IV
- 32.4%
- B/E move
- 3.7%
- Pseudo strike
- 304.89
- IV
- 31.1%
- B/E move
- 3.3%
35Δ
- Pseudo strike
- 318.75
- IV
- 32.6%
- B/E move
- 3.3%
- Pseudo strike
- 306.94
- IV
- 31.3%
- B/E move
- 2.8%
40Δ
- Pseudo strike
- 316.78
- IV
- 32.7%
- B/E move
- 2.9%
- Pseudo strike
- 308.99
- IV
- 31.4%
- B/E move
- 2.4%
45Δ
- Pseudo strike
- 314.82
- IV
- 32.8%
- B/E move
- 2.5%
- Pseudo strike
- 310.99
- IV
- 31.6%
- B/E move
- 2.1%
50Δ
- Pseudo strike
- 312.86
- IV
- 32.9%
- B/E move
- 2.2%
- Pseudo strike
- 312.95
- IV
- 31.9%
- B/E move
- 1.8%
55Δ
- Pseudo strike
- 310.90
- IV
- 33.0%
- B/E move
- 1.8%
- Pseudo strike
- 314.91
- IV
- 32.2%
- B/E move
- 1.5%
60Δ
- Pseudo strike
- 308.76
- IV
- 33.2%
- B/E move
- 1.5%
- Pseudo strike
- 316.86
- IV
- 32.4%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 306.47
- IV
- 33.7%
- B/E move
- 1.3%
- Pseudo strike
- 318.82
- IV
- 32.7%
- B/E move
- 1.0%
70Δ
- Pseudo strike
- 304.19
- IV
- 34.1%
- B/E move
- 1.1%
- Pseudo strike
- 321.02
- IV
- 32.7%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 301.91
- IV
- 34.5%
- B/E move
- 0.9%
- Pseudo strike
- 323.58
- IV
- 32.4%
- B/E move
- 0.6%
80Δ
- Pseudo strike
- 299.41
- IV
- 34.8%
- B/E move
- 0.7%
- Pseudo strike
- 326.15
- IV
- 32.0%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 28.05% | |
| 28.44% | |
| 29.18% | |
| 28.91% | |
| 28.37% | |
| 28.49% | |
| 28.98% | |
| 29.07% | |
| 27.86% | |
| 27.86% | |
| 28.69% | |
| 28.58% | |
| 28.35% | |
| 28.36% | |
| 28.99% | |
| 33.11% | |
| 32.47% | |
| 32.64% | |
| 31.56% | |
| 32.70% | |
| 34.04% | |
| 33.66% | |
| 32.24% | |
| 31.81% | |
| 31.82% | |
| 31.73% | |
| 31.79% | |
| 31.42% | |
| 32.27% | |
| 31.99% | |
| 32.43% | |
| 32.32% | |
| 31.90% | |
| 32.08% | |
| 32.95% | |
| 33.72% | |
| 33.67% | |
| 33.41% | |
| 33.67% | |
| 35.39% | |
| 35.35% | |
| 35.50% | |
| 34.60% | |
| 35.96% | |
| 36.45% | |
| 37.66% | |
| 36.61% | |
| 36.95% | |
| 37.00% | |
| 37.06% | |
| 37.64% | |
| 32.82% |
Medical Devices
TCMD
Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United States. The…
More →TLSI
TriSalus Life Sciences Inc. (TLSI) is an innovative biopharmaceutical firm at the forefront of enhancing cancer therapy through its proprietary localized drug delivery systems,…
More →TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and…
More →TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the…
More →TNDM
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company…
More →TXG
Description unavailable
More →